Immuneering Corporation

Q2 2022 13F Holders

Symbol
IMRX
CUSIP
45254E107
Type
Equity
Class
CLASS A COM
Num filings
38
Total reported value, excl. options
$65.7 M
Manager Report Date Value ($000) Shares Option Type